Back

Impact of anemia on clinical profile, treatment patterns and outcomes in heart failure: a retrospective cohort study

19 May 2025 (15:00 - 15:45)
Organised by: Logo
Congress Presentation Part of: Exploring precipitants of heart failure hospitalisation Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Weng Kee Ho

Sarawak General Hospital, Kuching (Malaysia)

6 More presentations in this session

Presentation thumbnail
Frequency and time intervals of worsening heart failure events in relation to terminal cardiac endpoints in patients with heart failure
Doctor K. Teramoto (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Genotype-driven prognostication in dilated cardiomyopathy
Doctor D. Hong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Non-obstructive coronary atherosclerosis increases risk of hospitalizations for heart failure
Doctor J. Matejka (Pardubice, CZ)
Abstract Slides Video
Presentation thumbnail
Low self-care ability may be associated with an increased risk of adverse outcomes in patients with decompensated heart failure
Doctor D. Kuanova (Aktobe, KZ)
Abstract Slides Video
Presentation thumbnail
Prognostic differences by sex in patients with de novo heart failure and reduced left ventricular ejection fraction. Insights from the COMFE Registry
Mr O. Otero Garcia (Santiago de Compostela, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Exploring precipitants of heart failure hospitalisation

The Event

Event poster

Heart Failure 2025

19 May 2025 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Effect of baseline and one-year follow-up anemia status on long-term clinical outcomes in patients with heart failure
thumbnail
Congress Presentation
Impact of anemia on the evolution of hospitalized HFpEF patients
thumbnail
Congress Presentation
Impact of anaemia on OAC prescription and adverse outcomes in patients with AF and chronic HF: an analysis form a real-world observational prospective study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources